These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices. Onaya T; Kotani M; Yamada T; Ochi Y J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046 [No Abstract] [Full Text] [Related]
5. The long-acting thyroid stimulator. Munro DS Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180 [No Abstract] [Full Text] [Related]
6. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results]. Tourneur R; Letonturier P; Sénécal P Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464 [No Abstract] [Full Text] [Related]
7. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator. Wong ET; Doe RP Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158 [No Abstract] [Full Text] [Related]
8. The long-acting thyroid stimulator of Graves' disease. Burke G Am J Med; 1968 Sep; 45(3):435-50. PubMed ID: 4876801 [No Abstract] [Full Text] [Related]
9. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS). Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477 [No Abstract] [Full Text] [Related]
10. The nature and significance of the long-acting thyroid stimulator. Kriss J Adv Metab Disord; 1968; 3():209-30. PubMed ID: 4178338 [No Abstract] [Full Text] [Related]
12. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology]. Strumia E Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606 [No Abstract] [Full Text] [Related]
13. Thyroid eye disease and its relationship to the long-acting thyroid stimulator. Hollows FC; Beaumont P Trans Aust Coll Ophthalmol; 1969; 1():37-44. PubMed ID: 4250318 [No Abstract] [Full Text] [Related]
14. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants]. Gautier E; Juillard E; Lemarchand-Béraud T Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264 [No Abstract] [Full Text] [Related]
16. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease. McKenzie JM; Zakarija M J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449 [TBL] [Abstract][Full Text] [Related]
17. The pathogenesis of thyrotoxicosis the discovery of LATS. Adams DD N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308 [No Abstract] [Full Text] [Related]
18. [Etiology of hyperthyroidism]. Lemarchand-Béraud T; Vannotti A; Griessen M Schweiz Med Wochenschr; 1967 Oct; 97(41):1342-52. PubMed ID: 5631864 [No Abstract] [Full Text] [Related]
19. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative). McKenzie JM Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791 [No Abstract] [Full Text] [Related]
20. [Graves-Basedow type ophthalmopathy and primary hypothyroidism]. Cathelineau G; Fribourg-Desi M Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586 [No Abstract] [Full Text] [Related] [Next] [New Search]